More changes ahead at Takeda Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M T Wed Th F 25 March, 2026

Every year, John Carroll sizes up the top 15 global pharma pipelines — then brings the findings live with the R&D chiefs shaping them. What's in, what's out, and what's next for 2026? Register now.

presented by Fu­ji­film ex­pands glob­al life sci­ences foot­print through large-scale bio­man­u­fac­tur­ing in­vest­ments

news The next oral peptide bet: Pinnacle Medicines gets $89M from US and China investors Exclusive: How Seaport is hedging against failure in Phase 2b depression study More changes ahead for Takeda with new CEO set to take reins

Head of Regulatory Strategy TCG stealth clinic-ready newco Boston, MA, USA Senior Director, Licensing Officer Bayer Cambridge, MA, USA Recruit talent with Endpoints Careers Contact Meg Estacio: mestacio@endpointsnews.com

US biopharma still leads the world in high-risk drug development, but the road from innovation to access has never been harder to predict. Hear from top executives and investors on how they’re navigating what’s next. Join us.

ENDPOINTS PHARMA FDA’s Denali approval defies recent trend of rare disease rejections FDA approves Corcept's Lifyorli for ovarian cancer months early Boehringer Ingelheim plans for dealmaking, obesity pipeline and R&D to counter US price pressure

in case you missed it 1. Merck to buy Terns for $6.7B, taking a leukemia drug that could challenge Scemblix 2. Beam looks to accelerated approval for AATD base editing after promising update 3. After tumultuous year, Sarepta plots rebound with early data on RNA therapies 4. Exclusive: Microneedle vaccine patch company raises $50M for pivot to GLP-1 delivery 5. News Briefing Novo reports more triple-G data from China; Grifols plots IPO for biopharma unit 6. Maze meets own expectations in Phase 2 kidney disease trial in the same arena as Vertex 7. Gilgamesh's psychedelics pipeline gets $60M backing after AbbVie deal 8. White House holds off on CDC pick as search for permanent chief continues 9. MAHA Surgeon General Pick Hits Republican Opposition in Senate

.